NEW YORK, Dec. 14 (GenomeWeb News) - TransTech Pharma signed a multi-year license for Genedata's high throughput screening-analysis software, Genedata said today.
TransTech Pharma scientists will use the software, Genedata Screener, to enhance their efforts to develop small molecules as therapeutics for treating human diseases. Screener has been integrated with TransTech Pharma's IT and screening infrastructure to automate data quality evaluation and standardize the analysis of compound bioactivity.
Financial details were not disclosed.